Rel and nuclear factor (NF)-B1, two members of the Rel/NF-B transcription factor family, are essential for mitogen-induced B cell proliferation. Using mice with inactivated Rel or NF-B1 genes, we show that these transcription factors differentially regulate cell cycle progression and apoptosis in B lymphocytes. Consistent with an increased rate of mature B cell turnover in naive nfkb1 Ϫ / Ϫ mice, the level of apoptosis in cultures of quiescent nfkb1 Ϫ / Ϫ , but not c-rel Ϫ / Ϫ , B cells is higher. The failure of c-rel Ϫ / Ϫ or nfkb1 Ϫ / Ϫ B cells to proliferate in response to particular mitogens coincides with a cell cycle block early in G1 and elevated cell death. Expression of a bcl-2 transgene prevents apoptosis in resting and activated c-rel Ϫ / Ϫ and nfkb1 Ϫ / Ϫ B cells, but does not overcome the block in cell cycle progression, suggesting that the impaired proliferation is not simply a consequence of apoptosis and that Rel/NF-B proteins regulate cell survival and cell cycle control through independent mechanisms. In contrast to certain B lymphoma cell lines in which mitogen-induced cell death can result from Rel/NF-B-dependent downregulation of c-myc, expression of c-myc is normal in resting and stimulated c-rel Ϫ / Ϫ B cells, indicating that target gene(s) regulated by Rel that are important for preventing apoptosis may differ in normal and immortalized B cells. Collectively, these results are the first to demonstrate that in normal B cells, NF-B1 regulates survival of cells in G0, whereas mitogenic activation induced by distinct stimuli requires different Rel/NF-B factors to control cell cycle progression and prevent apoptosis.
Summary
Rel and nuclear factor (NF)-B1, two members of the Rel/NF-B transcription factor family, are essential for mitogen-induced B cell proliferation. Using mice with inactivated Rel or NF-B1 genes, we show that these transcription factors differentially regulate cell cycle progression and apoptosis in B lymphocytes. Consistent with an increased rate of mature B cell turnover in naive nfkb1 Ϫ / Ϫ mice, the level of apoptosis in cultures of quiescent nfkb1 Ϫ / Ϫ , but not c-rel Ϫ / Ϫ , B cells is higher. The failure of c-rel Ϫ / Ϫ or nfkb1 Ϫ / Ϫ B cells to proliferate in response to particular mitogens coincides with a cell cycle block early in G1 and elevated cell death. Expression of a bcl-2 transgene prevents apoptosis in resting and activated c-rel Ϫ / Ϫ and nfkb1 Ϫ / Ϫ B cells, but does not overcome the block in cell cycle progression, suggesting that the impaired proliferation is not simply a consequence of apoptosis and that Rel/NF-B proteins regulate cell survival and cell cycle control through independent mechanisms. In contrast to certain B lymphoma cell lines in which mitogen-induced cell death can result from Rel/NF-B-dependent downregulation of c-myc, expression of c-myc is normal in resting and stimulated c-rel Ϫ / Ϫ B cells, indicating that target gene(s) regulated by Rel that are important for preventing apoptosis may differ in normal and immortalized B cells. Collectively, these results are the first to demonstrate that in normal B cells, NF-B1 regulates survival of cells in G0, whereas mitogenic activation induced by distinct stimuli requires different Rel/NF-B factors to control cell cycle progression and prevent apoptosis.
T he outcome of lymphocyte responses to antigenic or mitogenic activation reflects a balance between the relative rates of cell division, death, and differentiation (1) . Although signal transduction pathways that control cell survival and proliferation are the subject of intense investigation, in mature B cells little is known about the role of transcription factors in regulating these processes. Among the many transcription factors implicated in controlling gene expression in B lymphocytes (2) , the Rel (3) and nuclear factor (NF)-B1 (4, 5) subunits of the Rel/NF-B family have recently been shown to be essential for mitogen-induced proliferation. Rel/NF-B transcription factors are homoand heterodimeric proteins comprising subunits encoded by a small multigene family related to the c-rel protooncogene (6) . These proteins regulate transcription by binding to decameric sequences ( B motifs) located in the promoters and enhancers of many viral and cellular genes, particularly those encoding proteins involved in immune, acute phase, and inflammatory responses (6) (7) (8) . The five known mammalian Rel/NF-B proteins, NF-B1 (p50, p105), NF-B2 (p52, p100), RelA (p65), RelB, and Rel share a highly conserved 300-amino acid NH 2 -terminal Rel homology domain that encompasses sequences required for DNA binding, protein dimerization, and nuclear localization (6) . The CH 2 -termini of these proteins are divergent, with those of Rel, RelA, and RelB containing transcriptional transactivation domains (6, 9) . Before stimulation, in most cells, a large proportion of Rel/NF-B is retained in the cytoplasm in an inactive form through association with a family of inhibitor (I B) proteins (10, 11) . A wide range of stimuli promote the nuclear translocation of Rel/NF-B complexes by a mechanism involving the phosphorylation of conserved NH 2 -terminal serine residues in I B ␣ and I B ␤ (12, 13) , which targets these I B proteins for ubiquitin-dependent proteosome-mediated degradation (12) (13) (14) (15) .
To determine the physiological roles of the various Rel/ NF-B proteins, mice with inactivated c-rel (3), nfkb1 (4), relb (16, 17) , or rela (18) genes have been generated by gene targeting. rela Ϫ / Ϫ mice die at day 15 of embryogenesis, apparently as a result of fetal hepatocyte apoptosis (18) . In contrast, Rel (3), RelB (16, 17) , and NF-B1 (4) are not essential for embryogenesis, but are important in the function of hemopoietic cells. Although differentiation of stem cells into all hemopoietic lineages appears normal in c-rel Ϫ / Ϫ and nfkb1 Ϫ / Ϫ mice, Rel and NF-B1 are involved in controlling genes induced during immune responses. Mature B cells from both mutant strains are defective in their response to mitogens and antigens (3, 4) , whereas T cells and macrophages from c-rel Ϫ / Ϫ mice exhibit defects in the production of cytokines and immune regulatory molecules, including IL-2, IL-3, IL-6, GM-CSF, G-CSF, TNF-␣ , and iNOS (19, 20) . RelB appears to serve a dual role. Naive RelB Ϫ / Ϫ mice spontaneously develop hemopoietic lesions characterized by multifocal inflammatory infiltrates, myeloid hyperplasia, and splenomegaly (16, 17) . Although this phenotype suggests that RelB is important in regulating genes in hemopoeitic cells that are associated with constitutive or housekeeping functions, RelB Ϫ / Ϫ mice challenged with pathogens reveal that RelB is also involved in various specific and nonspecific immune responses (17) . Rel/NF-B proteins have also been implicated in the control of apoptosis. For example, loss of RelA renders embryonic fibroblasts highly sensitive to TNF-␣ -induced apoptosis (21) and expression of a trans -dominant I B ␣ mutant in various cell types markedly increases the death of these cells when treated with TNF-␣ , ionizing radiation, or daudorubicin (22, 23) . Although enforced expression of Rel can overcome TNF-␣ -induced apoptosis of HeLa cells expressing the trans -dominant I B ␣ mutant (24) , Rel has also been implicated as an inducer of cell death. Overexpression of Rel induces apoptosis in chicken bone marrow cells (25) and high levels of c-rel messenger RNA (mRNA) 1 were found in cells undergoing programmed cell death in the developing chick embryo (25) .
Although Rel and NF-B1 have been shown to be important in mitogen-induced B cell proliferation (3, 4) , it is not known whether these proteins are needed for cell cycle progression, inhibition of apoptosis, or both. Here we examine in detail defects in proliferation and cell survival of B cells from c-rel Ϫ / Ϫ and nfkb1 Ϫ / Ϫ mice. The results show that different mitogenic signals require Rel and/or NF-B1 to promote G1 progression during B cell division and that specific NF-B-like factors are necessary for the survival of quiescent and mitogen activated B cells.
Materials and Methods
Mice. The generation of the c-rel Ϫ / Ϫ (3) and nfkb1 Ϫ / Ϫ (4) mice and E -bcl-2-36 transgenic mice, which express a human bcl-2 cDNA in B and T cells (26) , has been described previously.
All mouse strains had been backcrossed for Ͼ 9 generations with C57BL/6 mice before being used for this study. c-rel Ϫ / Ϫ bcl-2 ϩ and nfkb1 Ϫ / Ϫ bcl-2 ϩ mice were generated by intercrossing the two parental mouse strains. Inheritance of the c-rel and nfkb1 mutant alleles and the bcl-2 transgene was determined by PCR analysis of tail biopsy DNA samples using specific oligonucleotide primers.
Purification of B Lymphocytes. Small, resting B lymphocytes were purified from spleens of 4-6-wk-old wild-type c-rel Ϫ/Ϫ , c-rel ϩ/Ϫ , or nfkb1 Ϫ/Ϫ litter-matched mice by negative cell sorting. In brief, all unwanted cells (granulocytes, macrophages, erythroid cells, and T lymphocytes) were stained with FITClabeled surface marker specific monoclonal antibodies (8C5 antiGr-1, M1/70 anti-Mac-1, Ter119, T24.31.2 anti-Thy1, KT3 anti-CD3, GK1.5 anti-CD4, and 53.6.72 anti-CD8) and dead cells were stained with the vital dye propidium iodide (PI; 1 g/ml). Viable cells that were not stained with the FITC-labeled monoclonal antibodies were purified on a FACS ® II or a FACStar Plus ® cell sorter (Becton Dickinson, San Jose, CA). The purity of all sorted B cells was verified by staining cells with a phycoerthyrin labeled anti-B220 antibody (CALTAG Labs., S. San Francisco, CA) and ranged between 97 and 99% purity.
B Lymphocyte Activation in Tissue Culture. B lymphocytes were cultured in the high glucose version of DMEM supplemented with 13 M folic acid, 250 M l-asparagine, 50 M 2-mercaptoethanol, and 10% fetal bovine serum at an initial concentration of 3 ϫ 10 5 /ml. Cells were stimulated in vitro with LPS (Difco, Detroit, MI) at a concentration of 20 g/ml, affinity purified goat anti-mouse IgM (FabЈ) 2 fragments (Jackson Immuno Research, Bar Harbor, ME) at 20 g/ml, rat anti-mouse CD40 monoclonal antibody FGK45 (a gift of Dr A. Rolink, Basel Institute, Basel, Switzerland) at 2 g/ml, or rat anti-mouse RP monoclonal antibody at 1 g/ml (27) . All stimulations were performed in the absence or presence of saturating concentrations of recombinant mouse interleukins, IL-2, IL-4, and IL-5.
Cell Turnover Studies. Cell turnover was determined by labeling proliferating cells in vivo with the thymidine analogue 5-bromo-2Ј-deoxyuridine (BrdU; Sigma Chemical Co., St. Louis, MO), which was provided continuously for 1, 3, or 7 d in the drinking water (1 mg/ml plus 2% glucose to overcome taste aversion). Drinking water bottles were shielded from light and exchanged after 3 days. Spleen cellularity did not alter significantly during the course of this treatment. BrdU incorporated into cellular DNA was detected by immunofluorescence staining with an FITC-labeled monoclonal antibody BU-1 (Becton Dickinson) and flow cytometric analysis performed according to published procedures (28) . In brief, cells were fixed in 0.5% paraformaldehyde in PBS (20 min at room temperature). As the BU-1 antibody only binds to BrdU within single-stranded DNA, the DNA was denatured using 3N HCl containing 0.5% Tween-20 to permeabilize cell membranes (20 min at room temperature). The acid was neutralized with 0.1 M disodiumtetraborate and cells were then stained (30 min) with FITC-BU-1 in the presence of 0.5% Tween-20. Combined analysis of incorporated BrdU and cell surface antigen expression to identify virgin and mature B cells was performed using a modified version of published procedures (28) . R-PE anti-IgM (CALTAG Labs.) and biotinylated anti-IgD (clone 11-26C) antibodies plus Tricolor-streptavidin (CALTAG Labs.) were used to identify virgin B cells (IgM ϩ IgD Ϫ ) and mature B cells (IgM ϩ IgD ϩ ). Cells were stained with biotinylated antibodies and fluorochrome conjugates after fixation and DNA denaturation with the exception of biotinylated anti-IgD, which had to be added beforehand. Flow cytometric analysis 665 Grumont et al.
(10,000 cells/sample) was performed on a FACScan ® . As a negative control for staining with FITC-BU-1 anti-BrdU antibody, we included cells from a mouse that had not received BrdU in the drinking water in all experiments. Routinely, Ͻ1% of such cells were stained above background. To verify that mice had incorporated BrdU and as a positive control for staining with FITC-BU-1, we routinely confirmed that cells with a high turnover rate, such as granulocytes within bone marrow, were strongly labeled.
Proliferation and RNA Synthesis Assays. B cells were cultured as described above in 100 l at a starting density of 3 ϫ 10 5 cells/ml in 96-well microtiter plates. Cellular proliferation and RNA synthesis were measured at various times by adding 0.5 Ci of [ 3 H]thymidine or 0.25 Ci of [ 3 H]uridine, respectively, for 6 h, after which cells were harvested onto glass fiber filters. Incorporated radioactivity was quantitated by scintillation counting.
Immunofluorescence Staining and Flow Cytometry. The expression of class II MHC, B7.2, and CD25 was analyzed on resting and anti-IgM-or anti-CD40-treated splenic B cells were stimulated for 24 h. Cells were surface stained with biotinylated monoclonal antibodies M5/114 (anti-class II MHC), GL-1 (anti-B7.2), PC16 (anti-IL-2 receptor ␣ chain CD25), or isotype-matched control monoclonal antibodies as described previously (3). Binding of biotinylated antibodies was revealed by staining with R-phycoerythrin-streptavidin (CALTAG Labs.) as the secondary reagent. Viable (PI negative) cells (5,000-10,000) were analyzed in a FACScan ® flow cytometer (Becton Dickinson). For the coculture experiments, c-rel Ϫ/Ϫ (Ly5.1) cells were separated from control c-rel ϩ/ϩ (Ly5.2) cells by cell sorting after staining with a biotinylated antiLy5.2 monoclonal antibody plus R-PE streptavidin.
Cell Cycle Analysis. Cell division in mitogen stimulated lymphocyte cultures was determined by assessing cellular DNA content using PI staining (29) . Cells were first fixed (Ͼ8 h at 4ЊC) in 70% ethanol, treated with 0.5 g/ml DNase-free RNase A (Boehringer Mannheim, Indianapolis, IN) for 20 min at room temperature, and finally stained with 69 M PI in 0.1 M sodium citrate (pH 7.4) for 30 min at 4ЊC. Flow cytometric analysis (10,000 cells/sample) was performed on a FACScan ® at a low flow rate (100-300 cells/s). Cell cycle distribution was determined with the Cellfit program (Becton Dickinson) or manual gating.
Analysis of DNA and Protein Content. Simultaneous analysis of cellular DNA and protein content was performed as described previously (30) . In brief, 5 ϫ 10 5 resting or mitogen-activated B cells were first fixed in ice-cold 70% ethanol (Ͼ8 h), washed once in phosphate-buffered saline, and resuspended at a cell density of ‫01ف‬ 6 cells/ml in PBS containing 0.5 g/ml Hoechst 33342 (HO; Calbiochem Corp., La Jolla, CA), 1 g/ml pyronin Y (Polysciences, Warrington, PA), and 0.1 g/ml FITC (isomer 1; BBL Microbiology Systems, Cockeyville, MD). Cells were stained for 30 min and then analyzed by flow cytometry using a modified dual lasar FACS ® II. Dead cells were excluded from analyses by gating on forward and side light scatter parameters. A total of 10,000 events were collected and analyzed using an in house computer program.
Northern Blot Analysis. 10 g samples of total RNA isolated from resting or anti-IgM antibody-activated B cells were fractionated on 1% formaldehyde agarose gels, transferred onto Hybond C Extra (Amersham Corp., Arlington Heights, IL) and sequentially hybridized as previously described (31) with a 32 Pradiolabeled mouse 1.4-kb XhoI c-myc cDNA (32) and a rat 1.1kb PstI glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA (33) . Both probes were labeled by random primer extension to specific activities ranging between 5 ϫ 10 8 and 10 9 cpm/g.
Results

Apoptosis of Quiescent B Cells Is Accelerated by the Loss of NF-B1, but Not by an Absence of Rel. To assess whether
Rel and NF-B1 have a role in regulating the survival of primary B cells, we first compared the rate of B cell turnover in normal, c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ mice. Splenic B cells isolated from mice administered BrdU in the drinking water continuously for up to 7 d were analyzed for BrdU incorporation using flow cytometry (Fig. 1 A) . Although no significant difference was observed in the rate of BrdU incorporated by surface (s)IgM ϩ sIgD Ϫ or sIgM ϩ sIgD ϩ splenic B cells after 2 d, by days 4 and 7 of this kinetic analysis, nfkb1 Ϫ/Ϫ B cells had incorporated between two-and fourfold more BrdU than either normal or c-rel Ϫ/Ϫ B cells. To determine if the increased turnover of nfkb1 Ϫ/Ϫ B cells in vivo could be due to enhanced cell death, the survival of resting splenic B cells from mice of each strain were examined in tissue culture (Fig. 1 B) . As expected, normal B cells did not proliferate in the absence of mitogens (results not shown), and a significant proportion had died by apoptosis over the course of 72 h. c-rel Ϫ/Ϫ B lymphocytes behaved indistinguishably from control cells, whereas the frequency of apoptotic cells was higher in cultures of quiescent nfkb1 Ϫ/Ϫ B cells. Collectively these findings suggest that the survival of resting B cells is dependent on NF-B1, but not Rel.
Rel and NF-B1 Are Required for Cell Cycle Progression and Survival of Mitogen-stimulated B Cells.
To determine if the role of Rel and NF-B1 in B cell proliferation involves the regulation of cell division and/or apoptosis, we performed cell cycle and cell death analysis on mitogen-activated splenic B cells from c-rel Ϫ/Ϫ , nfkb1 Ϫ/Ϫ , and control mice. Purified B lymphocytes were stimulated with LPS or crosslinking antibodies specific for IgM or the B cell-specific membrane protein, RP (27) in the presence or absence of cytokines. Cell proliferation and apoptosis were assessed daily over a 72-h time course by cell counting, [ 3 H]thymidine incorporation, and flow cytometric analysis of cellular DNA content. The proliferation, apoptosis, and cell division data for all mitogenic stimulations is graphically summarized in Fig. 2 . The first 24 h of a normal mitogenic response is characterized by apoptosis and a low level of cell division. The extent of cell death is dependent on the stimulus, varying between 15 (LPS) and 44% (anti-IgM antibody) (Fig. 2 B) . Between 24 and 72 h, a reduction in the frequency of dead cells coincides with an increase in viable cells due to division ( Impaired c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cell proliferation coincides with higher than normal levels of apoptosis (Fig. 2  B) and reduced cell division (Fig. 2 C) , the extent of which both vary in a mitogen-specific manner. anti-IgM or -RP antibody-treated c-rel Ϫ/Ϫ and LPS-stimulated nfkb1 Ϫ/Ϫ B cells in S and G2/M indicated that these cells appear to be blocked at an earlier point in the cell proliferative cycle. Although the partial enlargement of mitogen-treated c-rel Ϫ/Ϫ B cells was consistent with progression to an early phase in G1 (36) (37) (38) , the G1 state can be subdivided into early and late phases; the late phase being characterized by an increased rate of RNA and protein synthesis (35) . To define the point in the cell cycle at which c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells arrest, RNA synthesis was monitored in mitogen-treated B cells by [ 3 H]uridine incorporation. (Fig. 5 B) . c-rel Ϫ/Ϫ cells treated with anti-RP antibody alone fail to progress to G1, whereas a significant proportion of anti-RP antibody plus cytokinestimulated c-rel Ϫ/Ϫ B cells can progress via G1 into S phase and G2/M (Fig. 5 B) . These results demonstrate that c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells are blocked at a point early in G1 that precedes increased RNA and protein synthesis and that cytokines can partly overcome this cell cycle block allowing c-rel Ϫ/Ϫ cells to progress through S plus G2/M.
Expression of a bcl-2 Transgene Inhibits Apoptosis but Does Not Overcome the Cell Cycle Defect.
To further understand the mechanism(s) by which Rel and NF-B1 prevent apoptosis in B lymphocytes, we tested whether the expression of a bcl-2 transgene could inhibit the apoptosis of c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells. Survival curves for nonstimulated normal, c-rel Ϫ/Ϫ , and nfkb1 Ϫ/Ϫ B cells expressing bcl-2 (Fig. 6 A) show that in addition to inhibiting the death of normal quiescent B cells, a finding consistent with previous reports (39), bcl-2 prevented the enhanced apoptosis of resting nfkb1 Ϫ/Ϫ B cells. Analysis of apoptosis and cell division in mitogen-stimulated c-rel ϩ/ϩ bcl-2 ϩ and c-rel Ϫ/Ϫ bcl-2 ϩ B cell cultures reveals that bcl-2 also prevented the death of antiIgM-and anti-RP-treated c-rel Ϫ/Ϫ B cells (Fig. 6 C) , but failed to promote cell division (Fig. 6, B and D) . Collectively, these findings show that the death of B cells resulting from an absence of Rel or NF-B1 belong to that class of apoptosis that can be inhibited by bcl-2. (Table 1) . Based on these results, B cell mitogens can be categorized into two groups: those which do or do not cooperate to promote cellular proliferation in the absence of Rel. 
c-myc Expression Is Normal in Mitogen-stimulated c-rel
Discussion
We have demonstrated that Rel and NF-B1, subunits of the Rel/NF-B family of transcription factors, differentially regulate cell cycle progression and apoptosis in B lymphocytes. NF-B1 prevents apoptosis in quiescent cells, whereas both Rel and NF-B1 are important for the survival of mitogen-activated B cells. Differences in the proliferative defects exhibited by B cells lacking Rel or NF-B1 also indicate that the requirement of one or both of these transcription factors for progression through the G1 phase of the cell cycle is dependent on the particular mitogenic signal. 8) and 4 h (lanes 9-12) were fractionated on formaldehyde denaturing gels, transferred to nitrocellulose membranes, and sequentially hybridized with radiolabeled murine c-myc cDNA (32) upregulated in the nucleus (4; Grumont, R.J., results not shown). In contrast, c-rel Ϫ / Ϫ B cells stimulated with this mitogen fail to proliferate, even though nuclear NF-B1/ RelA heterodimers and NF-B1 homodimers are upregulated with normal kinetics (3) . Taking into consideration the recent finding that proliferation of anti-IgM antibodystimulated rela Ϫ / Ϫ B cells is also impaired (48) , this indicates that B cell mitogenesis triggered by engaging the antigen receptor only requires Rel/RelA heterodimers and Rel homodimers. LPS-dependent B cell proliferation, however requires Rel, RelA, and NF-B1 (3, 4, 48) .
Certain mitogen combinations such as anti-IgM antibody and LPS, anti-RP antibody and LPS, or anti-RP antibody plus cytokines synergistically enhance B cell proliferation by increasing cell division and reducing apoptosis, whereas others such as anti-IgM and anti-RP antibodies fail to increase c-rel Ϫ / Ϫ B cell mitogenesis above that promoted by the individual stimuli. These findings are consistent with models in which dual stimuli partly overcome the proliferative defect as a result of each mitogen activating distinct intracellular signals required for survival and/or cell cycle progression. Conversely, it would appear that nonsynergizing mitogens such as anti-IgM plus anti-RP antibodies engage the same or functionally equivalent signaling pathways. If Rel controls a single pathway crucial for the division and survival of B cells, then perhaps multiple mitogens can in part bypass the need for Rel by engaging the pathway downstream of Rel. The molecular basis of mitogen synergy remains to be determined. This could involve activation of other NF-B-like complexes, or Rel/NF-B-independent signal transduction pathways. The second possibility is consistent with the finding that mitogen-activated protein (MAP) and stress-activated protein (SAP) kinases are activated normally in c-rel Ϫ / Ϫ B (results not shown).
In B Cells, Rel and NF-B1 Regulate G1 Cell Cycle Progression. c-rel Ϫ / Ϫ and nfkb1 Ϫ / Ϫ B cells undergo abortive mitogenic responses characterized by initial cell enlargement but failure to undergo RNA and protein synthesis. This indicates that cell cycle arrest occurs at a stage between early and late G1. Consistent with Rel and NF-B1 controlling cell cycle progression is the recent finding that the cyclin-dependent kinase Cdk2 can regulate the transcriptional activation of RelA through mutual interaction with the coactivator p300 (49) . Our data also shows that the involvement of particular Rel/NF-B subunits in cell cycle regulation may be cell-type specific. Although NF-B1 is important for B cell division and NF-B (NF-B1/ RelA) is induced in fibroblasts during the G0 to G1 transition (50), mitogen-stimulated primary fibroblasts that lack NF-B1 divide normally (Gerondakis, S., unpublished results).
The synergistic action of mitogen combinations in promoting c-rel Ϫ / Ϫ B cell proliferation (e.g., anti-RP antibodies plus cytokines) demonstrates certain signals permit near normal numbers of c-rel Ϫ / Ϫ B cells to progress through G1 and complete the cell cycle. Although this indicates that neither Rel nor NF-B1 appear to be essential at other (25, 51, 52) roles. Such a dual function for particular Rel/NF-Blike factors may depend on the cell type and the nature of the apoptotic signal. For example, the importance of cell type is emphasized with NF-B1 protecting resting and LPS-treated B cells from apoptosis (this paper) while being dispensible for survival of TNF-␣-treated embryonic fibroblasts (21) . Quantitative differences in the survival of c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells treated with different mitogens also emphasizes the complex relationship between Rel/NF-B-dependent mitogenesis and apoptosis.
It remains to be determined how Rel and NF-B1 promote the survival of B lymphocytes and which gene(s) crucial to cell survival are regulated by these transcription factors in quiescent and mitogen-stimulated cells. Since Rel and NF-B1 can function both as a transcriptional activators or repressors (4, 19, 20) , cell survival mediated by these proteins could result either from the induction of a survival gene or repression of a cell death gene. Candidate gene(s) include those specifically dedicated to controlling cell survival, or in the case of mitogen-stimulated c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells, these could be cell cycle genes if enhanced levels of death are an indirect consequence of the impaired expression of genes required for G1 progression. Support for the former model comes from the finding that even though mitogen-induced rela Ϫ/Ϫ B cell proliferation is impaired, apoptosis is normal (48) , suggesting that the defects in mitogen-treated c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells could be the result of Rel and NF-B1 regulating two distinct groups of genes, one crucial for cell cycle progression and the other apoptosis. Moreover, it appears likely that Rel/NF-B factors regulate the expression of more than one gene important for lymphocyte survival. Although c-myc is a crucial regulator of cell division and apoptosis (53) and anti-IgM-treated W231 B lymphoma cells undergo apoptosis due an inhibition of Rel/NF-B-dependent c-myc transcription (40, 41) , the expression of c-myc was normal in quiescent or anti-IgM-treated c-rel Ϫ/Ϫ and nfkb1 Ϫ/Ϫ B cells. This difference may indicate that the regulation of c-myc transcription differs in primary and immortalized B cells. NF-B-induced cellular inhibitor of apoptosis protein 2 (c-IAP2) expression was also shown to be important in preventing the TNF-␣-mediated death of Jurkat T cells (54) , yet the absence of Rel or NF-B1 does not alter c-IAP2 expression in B cells (results not shown). Ultimately, the identification of Rel/NF-B-regulated genes in B cells that are important for cell cycle regulation and cell survival should offer important insight into the mechanisms by which different Rel/NF-B dimers regulate these processes in response to particular mitogenic signals.
